The combined Universities of Sydney and Otago’s Australia and New Zealand (ANZ) Microsurgical Skills Course at the Sydney Eye Hospital has gone from strength to strength since it was established in 2019, with its now twice-yearly 20 places booked months in advance and organisers considering a waitin
In March 2022, the breakthrough gene therapy treatment Luxturna was approved for public funding in Australia, two years after the UK did so and four years after it was fast-tracked to become the first FDA-approved gene therapy. Designed for people with vision loss caused by inherited retinal dystrop
Committed to creating a more sustainable future, Alcon is the latest contact lens company to partner with Plastic Bank, a social enterprise whose mission is to clean up the world’s oceans and waterways.
A UK team has developed a predictive tool to help young keratoconus patients make informed decisions about undergoing corneal crosslinking (CXL) to halt disease progression.
A US study has found lower baseline corneal hysteresis (CH) to be a significant risk factor for glaucomatous central and peripheral visual field (VF) progression. CH is a measure of the viscoelastic damping of the cornea, which reflects the ability of the cornea to absorb and dissipate energy.
Swiss health startup Vivior has developed a wearable device to objectively measure patients’ behavioural data to optimise intraocular lens (IOL) choice.
Selected from 3,900 nominations, Lumenis’ OptiLight technology for the treatment of dry eye disease (DED) has received MedTech Breakthrough’s Best New Technology Solution for Ophthalmology award.
Abraham Lincoln suffered from double vision caused by intermittent vertical hypertropia. Biographers have speculated this, combined with his physical characteristics – notably his 6’4” frame – suggests the 16th US president had Marfan syndrome, as did Lincoln’s great-great-grandfather.
US researchers have stimulated blind rat retinas with ultrasound, enabling them to perceive basic shapes, a technique they said could allow a non-invasive therapy for some forms of blindness.
Increased access to OCT in clinical practice is transforming age-related macular degeneration (AMD) patient management, diagnosing the disease earlier than before, according to Specsavers’ data. The five-year transformation seen in Australia, supported by the evolving Royal Australian and New Zealan
US-based researchers have demonstrated a link between diet, circadian rhythms, eye health and lifespan for the first time, in a study on Drosophila.
